Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.
NANT Cancer Vaccine, also called Cancer BioShield, is an investigational cancer vaccine and immune-platform concept. It is designed to help the immune system recognize and attack cancer cells by presenting tumor antigens—specific markers found on cancer cells. This approach is part of combination immunotherapy, which uses multiple immune-based treatments together to try to improve the body’s ability to fight cancer. The vaccine is personalized or platform-based, meaning it may be tailored to the individual’s cancer or use a broader immune activation strategy.
This vaccine concept appears in cancer-related discussions because it is connected with various goals, including cancer prevention, active treatment, symptom relief, recovery, and survivorship support. Cancer vaccines are an active area of research, aiming to improve immune responses against tumors. However, NANT Cancer Vaccine / Cancer BioShield is still experimental, and its safety and effectiveness depend on ongoing clinical trials and regulatory review. It may be considered as part of combination immunotherapy strategies that seek to boost immune activation against cancer.
Patients might encounter this term in treatment plans, clinical trial descriptions, or discussions about immunotherapy options. It may be mentioned by clinics, researchers, or alternative-health communities. Because cancer patients often have special vulnerabilities—such as immune suppression, bleeding risk, organ impairment, or drug interactions—it is important to review any proposed use of this vaccine with healthcare providers who understand the patient’s full medical situation. The vaccine may be presented as a direct anticancer strategy or as supportive care to improve quality of life or resilience during treatment.
Seeing the term NANT Cancer Vaccine or Cancer BioShield does not mean the vaccine is a proven or standard treatment. It is investigational and should not be interpreted as a guaranteed cure or a substitute for conventional cancer therapies. Claims about detoxifying the body, repairing DNA, or curing cancer should be viewed cautiously unless supported by strong clinical evidence. The vaccine is part of ongoing research and may be offered only in clinical trial settings or specialized centers.
This entry is educational and not a recommendation to use the vaccine. Patients should discuss any interest or questions about NANT Cancer Vaccine / Cancer BioShield with their oncology team. Doctors will consider the patient’s diagnosis, stage, pathology, current treatments, medications, lab results, and overall goals of care before recommending any new or experimental therapy. Understanding contraindications and potential risks is important, especially given the complex health needs of many cancer patients.
If you see this term in your medical records, treatment plan, or research, ask your care team what it means in your specific case. Clarify how it fits into your overall treatment strategy, what evidence supports its use, and what safety considerations apply. Your healthcare providers can help you weigh the potential benefits and risks and guide you toward treatments best suited to your individual situation.